TAI:4155
OK Biotech Co., Ltd. · TAI · Healthcare · TWD · FY for 2025
Figures on this page computed 2026-11-06 13:58 UTC
Last close
n/aTWD
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
28.2xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- computed
- Computed from the filing for 2025
3.1%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
5.3%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
-5.8%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
0.41Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
1.6%Dividend yield
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- computed
Growth is the furthest below its sector's middle: 0.22 against 0.47 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales1.17x
Its own average over 10 years, 1.33B.
- Profit0.84x
Its own average over 10 years, 98.3M.
- Free cash flow1.50x
Its own average over 10 years, -59.7M.
- Debt1.90x
Its own average over 10 years, 543.8M.
- Pricen/a
Its own average over 0 years. Market data
Debt is furthest from its own average, at 1.90 times.
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2016-12-31 | 100.0 | 100.0 | 100.0 |
| 2017-12-31 | 118.5 | 148.8 | 102.3 |
| 2018-12-31 | 107.7 | 189.4 | 115.9 |
| 2019-12-31 | 119.3 | 147.6 | 131.0 |
| 2020-12-31 | 142.7 | 152.3 | 148.6 |
| 2021-12-31 | 121.4 | 36.9 | 176.6 |
| 2022-12-31 | 142.6 | 168.4 | 194.1 |
| 2023-12-31 | 114.6 | 3.5 | 188.3 |
| 2024-12-31 | 160.5 | 110.3 | 214.7 |
| 2025-12-31 | 149.6 | 96.8 | 245.6 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- TWD
How profit was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- TWD
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- TWD
Figures behind the shape
Growth
0.9%faster is higher, placed against 4,940 companies as of 2026-11-05
Five-year revenue growth rate0.9%
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- computed
Five-year EPS growth rate-16.0%
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- computed
One-year change in net income-12.3%
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- computed
Returns on capital
3.1%higher is higher, placed against 5,079 companies as of 2026-11-05
Return on invested capital3.1%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity3.3%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets2.1%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
Margins
27.6%wider is higher, placed against 3,410 companies as of 2026-11-05
Gross margin27.6%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin6.9%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin5.3%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin-5.8%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
Price
28.2xcheaper is higher, placed against 4,359 companies as of 2026-11-05
Price to earnings28.2x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- computed
- Computed from the filing for 2025
Price to book1.1x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDA17.2x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio1.8x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
Safety
0.41safer is higher, placed against 3,226 companies as of 2026-11-05
Debt to equity0.41
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio2.28
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage9.9x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score2.04
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
What it pays out
1.6%more, and better covered, is higher, placed against 1,089 companies as of 2026-11-05
Dividend yield1.6%
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- computed
Payout ratio53.1%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ratio-2.0x
- Source
- computed
- Taken on
- 2026-11-06
- Reported in
- TWD
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.